PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID

PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID

During steps of drug development area determination the decision area was framed providing isolation observed work activities from operating activities in order to set task achievement in specified time. Represented in the present paper approach to process analysis and implementation (including prod...

Full description

Saved in:

Bibliographic Details
Main Author:	Yu. V. Vlasenko
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	pharmaceutical development pharmaceutical substance amoxicillin clavulanic acid quality system
Online Access:	https://www.pharmjournal.ru/jour/article/view/219
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Rare Case of Actinomycetoma In Pregnancy: Effective Treatment with the Combination of Amoxicillin-Clavulanic Acid
by: Hidayah RMN, et al.
Published: (2025-08-01)

Lingua Villosa Nigra Developing After Amoxicillin-Clavulanic Acid Use in a Pediatric Patient: A Case Report
by: Feride Özen, et al.
Published: (2021-09-01)

Efficacy of antimicrobials or placebo compared to amoxicillin-clavulanate in children with acute otitis media: a systematic review
by: Katerina Tsergouli, et al.
Published: (2023-06-01)

Clinical Effects of Amoxicillin-clavulanate and Calcium Hydroxide as Intracanal Medicament on Inter appointment Pain among Symptomatic Apical Periodontitis
by: Naresh Kumar, et al.
Published: (2021-10-01)

Simultaneous determination of amoxicillin and clavulanic acid in the human plasma by high performance liquid chromatography: Mass spectrometry (UPLC/MS)
by: Ćirić Biljana, et al.
Published: (2010-01-01)

Amoxicillin/Clavulanic Acid in Transrectal Biopsy of the Prostate—An Alternative in Times of Ciprofloxacin Obsolescence and Fosfomycin Limitation?
by: Philipp J. Spachmann, et al.
Published: (2024-10-01)

Exploring of spectroscopic, dielectric, and bioactivity performance of bioglass/sodium alginate-PVP loaded-Amoxicillin/Clavulanic Acid microspheres for bone tissue engineering
by: Ahmed M. Bakr, et al.
Published: (2025-05-01)

Unintentional Azithromycin Overdose and Prolonged Therapy with Amoxicillin/Clavulanate without the Development of Hepatotoxicity in a Patient with Type I Diabetes: Case Description
by: I. V. Andreeva, et al.
Published: (2020-05-01)

Comparative effectiveness of amoxicillin versus amoxicillin‐clavulanate among adults with acute sinusitis in emergency department and urgent care settings
by: Suzette A. Rovelsky, et al.
Published: (2021-06-01)

Effectiveness of protected aminopenicillins in treatment of non-social pneumonia in children
by: E. E. Krasnova, et al.
Published: (2021-11-01)

Generic giants to biotech frontiers: mapping India’s pharma trajectory—part I
by: Prasanta Kumar Ghosh
Published: (2025-04-01)

Rational Etiotropic Treatment of Upper Respiratory Tract Infections. Problems of Antibiotic Resistance of Community-Acquired Infections
by: I. A. Karpov, et al.
Published: (2020-05-01)

Development and Validation of Bioanalytical LC–MS/MS Method for Pharmacokinetic Assessment of Amoxicillin and Clavulanate in Human Plasma
by: Sangyoung Lee, et al.
Published: (2025-07-01)

Retrospective analysis of adverse drug reaction reporting forms associated with penicillin family antibiotics (pcne-drp 9.0) based on drug-related approach
by: A. V. Matveev, et al.
Published: (2020-05-01)

A Comparative Evaluation of Risk Factors and Various Antibiotic Regimens in Postoperative Neurosurgical Infections: A Prospective Randomized Controlled Study
by: R. Shetty, et al.
Published: (2017-10-01)

Features and benefi ts of using new forms of antibiotics with improved pharmacokinetic properties
by: А. L. Vertkin, et al.
Published: (2022-10-01)

ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
by: K. O. Sidorov, et al.
Published: (2019-01-01)

Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
by: Jun Qiu, et al.
Published: (2025-01-01)

Drug-induced enterocolitis syndrome in children: report of two cases and a literature review
by: Murat Özer, et al.
Published: (2025-02-01)

Metabolomic Profile Modification in the Cerebellum of Mice Repeatedly Exposed to Khat and Treated with β-Lactamase Inhibitor, Clavulanic Acid
by: Abdulkareem A. Alanezi
Published: (2024-12-01)

Youth Should Be Part of African Pharma Industry—A Perspective
by: Samuel Inshutiyimana
Published: (2025-04-01)

The directions of improvement of terminological approaches to defi nition «the pharmaceutical sphere» in a context of legal responsibility of participants of legal relationship who arise during a turn of medicines
by: E. G. Knysh, et al.
Published: (2013-10-01)

Development of a β-lactamase-based aggregation-induced emission lateral flow strip for the detection of clavulanic acid in Milk
by: Xiaonan Wang, et al.
Published: (2024-12-01)

THE MANUFACTURING OF PHARMACEUTICAL INGREDIENTS IN RUSSIAN FEDERATION: THE CRISIS AT THE TURN OF XX TO XXI CENTURIES
by: E. V. Denisova
Published: (2019-01-01)

Development of Retraining Systems for the Implementation of the Pharmaceutical Quality System at Pharmaceutical Production Enterprises of the EAEU Countries
by: V. A. Smirnov, et al.
Published: (2021-02-01)

Problematic aspects of staffing the domestic pharmacy segment in the context of pharmaceutical safety
by: N. O. Tkachenko, et al.
Published: (2025-03-01)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

Pharmaceutical Substances. Requirements of the State Pharmacopoeia for Their Standardization
by: E. I. Sakanyan, et al.
Published: (2020-05-01)

The introduction of digital twins into the production cycles of biotech companies in the context of the Pharma 4.0 concept
by: L. V. Lapidus, et al.
Published: (2024-10-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice
by: N. A. Bilousova
Published: (2024-11-01)

Analysis of pharmaceutical technical staff needs at hospital X in Bandung using the WISN method
by: Angela Alysia Elaine, et al.
Published: (2024-11-01)

PRINCIPLES OF ANTIBIOTIC TREATMENT OF OUT-OF-HOSPITAL UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN
by: A. L. Zaplatnikov, et al.
Published: (2012-03-01)

Pharmaceutical care as a historical, normative-legal and social-economic category in the system of the population health and pharmaceutical care
by: G. L. Panfilova
Published: (2014-08-01)

Pharmacoeconomic analysis of using drugs containing mycophenolic acid in kidney transplant recipients in the context of domestic pharmaceutical market
by: V. N. Lesovoy, et al.
Published: (2015-08-01)

IN MEMORY OF PROFESSOR V.G. BELIKOV
by: B. V. Borovsky, et al.
Published: (2015-09-01)

IDENTIFICATION OF PHARMACEUTICAL PRODUCTS IN ACCOUNTING SYSTEM: PROBLEMS OF HARMONIZATION
by: M. I. Skrypnyk, et al.
Published: (2018-12-01)

Some aspects of liposomal oxaliplatin formulations
by: A. V. Stadnichenko, et al.
Published: (2015-02-01)

Organic Solvents for Determination of Bacterial Endotoxin Index in Water-Insoluble Pharmaceutical Substances
by: O. V. Shapovalova, et al.
Published: (2020-05-01)